Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page
- Check4 days agoChange DetectedPage revision label updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the page. This change does not alter the study details, eligibility criteria, or other content presented on the page.SummaryDifference0.1%

- Check11 days agoChange DetectedThe site software revision was updated from v3.6.0 to v3.6.2, indicating a platform update. This change does not alter the displayed study details or user-facing content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment is closed, and new sections How to Read a Study Record, Common Questions, and How to Join a Study were added to guide users, while the Intervention/Treatment label formatting and revision version notes were updated (v3.6.0 replacing v3.5.5).SummaryDifference0.5%

- Check32 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page. This reflects a site version update without changes to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata. The core study information remains unchanged.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision stamp Revision: v3.5.3 has been added, replacing the previous Revision: v3.5.2. This reflects a software release update shown on the page's footer.SummaryDifference0.1%

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.